68Ga-Based radiopharmaceuticals: production and application relationship - Wikidata - wikimedia - TriplyDB

68Ga-Based radiopharmaceuticals: production and application relationship

68Ga-Based radiopharmaceuticals: production and application relationship

http://www.wikidata.org/entity/Q26801794

about

Feasibility of Multiple Examinations Using (68)Ga-Labelled Collagelin Analogues: Organ Distribution in Rat for Extrapolation to Human Organ and Whole-Body Radiation Dosimetry.68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies Novel bifunctional DATA chelator for quick access to site-directed PET (68)Ga-radiotracers: preclinical proof-of-principle with [Tyr(3)]octreotide.Equilibrium, Kinetic and Structural Properties of Gallium(III) and Some Divalent Metal Complexes Formed with the New DATAm and DATA5m Ligands.Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging.Preparation of an 18 F-Labeled Hydrocyanine Dye as a Multimodal Probe for Reactive Oxygen Species.Exploring Metabolism In Vivo Using Endogenous 11C Metabolic Tracers.Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling† †Electronic supplementary information (ESI) available. CCDC 1564603. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c7ra09076e.Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?Evaluation of the Possible Utilization of 68Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer.Convenient Preparation of [(68)Ga]DKFZ-PSMA-11 Using a Robust Single-Vial Kit and Demonstration of Its Clinical Efficacy.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.Development of a 68Ge/68Ga Generator System Using Polysaccharide Polymers and Its Application in PET Imaging of Tropical Infectious Diseases.

P2860

Q30379281-B931BBF3-0D76-4E1C-8588-35C92D17972A Q36163785-2C1398A6-3A8D-462F-B45F-E2295B1B8204 Q38694747-EFE9AE84-6316-4CAF-8D10-0872FC0FC3C7 Q38786041-E1A8447B-22DE-438F-AC81-73D30D3801F3 Q39030223-7991CDCE-F70C-49C5-947E-1A6C438968E5 Q41019277-B8E69BD4-329F-4756-AE7F-3EB797174B8B Q41083360-3EEE92F7-68E3-44C8-B45F-1CB7AA97280E Q41481562-594707A4-9979-4941-BF21-F03BEEE4C377 Q46474055-8A1A760B-4F62-416D-97E2-24BE3939DAE8 Q46851666-4A62A1CF-F222-47D2-A6D6-6DED8F795048 Q47115169-B3A2FB79-42D9-454A-8A18-2FA499729736 Q47195725-5E4E551A-C4A3-4C59-B1CA-33A5FAA5D9CD Q48089118-590983CE-A2B0-48FE-8782-2E14902CA5A2 Q49353240-7B07FAE5-0C32-4922-8416-CAAA285D22C7 Q50049100-4F4ECEB4-75BB-402B-947F-8E6072414A52 Q51440427-E17197DC-DA97-46CA-9A37-E00A370EBF37 Q54257268-C182C8CB-64F1-480E-9E34-C3458354B1FE Q55689445-53645A17-937F-4193-B1BF-9A2664CCA5AC

P2860

68Ga-Based radiopharmaceuticals: production and application relationship

http://www.wikidata.org/entity/Q26801794

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

68Ga-Based radiopharmaceuticals: production and application relationship

@ast

68Ga-Based radiopharmaceuticals: production and application relationship

@en

68Ga-Based radiopharmaceuticals: production and application relationship

@nl

type

label

68Ga-Based radiopharmaceuticals: production and application relationship

@ast

68Ga-Based radiopharmaceuticals: production and application relationship

@en

68Ga-Based radiopharmaceuticals: production and application relationship

@nl

prefLabel

68Ga-Based radiopharmaceuticals: production and application relationship

@ast

68Ga-Based radiopharmaceuticals: production and application relationship

@en

68Ga-Based radiopharmaceuticals: production and application relationship

@nl

P1433

Q26801794-2A9E76CB-D1ED-4CD2-A134-E5D9BD47AEA4

P1476

Q26801794-CB04BED7-2234-4E98-AB5C-0B5776C976DD

P2093

Q26801794-95452D22-BD52-490A-A046-26390534F9D7

P2860

Q26801794-0FDCDEBD-6A11-4056-9905-134017D2658C

Q26801794-1CFC4A5B-C896-42B6-9630-D88E0FBF8CE9

Q26801794-1FFCD695-CB61-4548-B212-3DE684AC8391

Q26801794-20AE90BB-9FD0-4967-BBE4-FFC10CD2D124

Q26801794-29BA363B-4CAB-442A-8DE1-80C634FF4905

Q26801794-2BB2B132-3614-402B-A887-878E7467FE0B

Q26801794-2C0F496B-DB09-460B-8F0E-6A6DD173869E

Q26801794-2D878213-E849-45E4-9D4B-CBDBDD2DF81D

Q26801794-2DD39C56-F261-49ED-93D2-61C15FD1DD42

Q26801794-31C65341-C2C1-4684-876D-D52BB834C508

P304

Q26801794-FD70ACAF-A753-42CB-B703-DB2416ED1028

P31

Q26801794-267FD136-1140-4B8A-BE40-2E5127E46A5C

P3181

Q26801794-93924FAB-E594-4F36-AFB7-560A2870383B

P356

Q26801794-161368FD-5CC5-473F-A8C1-8A1C9CF164A6

P407

Q26801794-65387E3D-C929-42EC-A032-FD70C9B23F5D

P433

Q26801794-7393F439-6BA0-4D22-B319-85DD8774A0F4

P478

Q26801794-FCC78555-D7ED-45E7-9D65-EAAE5DD5A066

P577

Q26801794-BE3DB9B2-A321-454D-97BF-24BBE56CD1CB

P5875

Q26801794-703B3B3B-BD04-4354-A16E-0DF92C6F372C

P698

Q26801794-B632F11C-C627-47EF-A3AC-C435E6EDFDD9

P932

Q26801794-0AF1DD43-35A2-43C6-B266-852CC0A834E7

P3181

P356

MOLECULES200712913

P1433

P1476

68Ga-Based radiopharmaceuticals: production and application relationship

@en

P2093

Irina Velikyan

http://www.w3.org/2001/XMLSchema#string

P2860

Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity.

68Ga-labeling of biotin analogues and their characterization.

In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass.

Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.

A new automated NaCl based robust method for routine production of gallium-68 labeled peptides.

Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.

Reduction of (68)Ge activity containing liquid waste from (68)Ga PET chemistry in nuclear medicine and radiopharmacy by solidification

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials

Prospective of ⁶⁸Ga-radiopharmaceutical development.

P304

12913-12943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1027058

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/MOLECULES200712913

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281821109

http://www.w3.org/2001/XMLSchema#string

P698

26193247

http://www.w3.org/2001/XMLSchema#string

P932

6332429

http://www.w3.org/2001/XMLSchema#string